genetics
| 4 min read
Sepsis antibody breakthroughs, a billion-dollar KRAS deal, and FDA’s push to rebuild domestic drug manufacturing led the drug discovery news this week.
| 4 min read
For rare and inherited kidney diseases, genetic testing is solving the clinical trial recruitment crisis and reshaping how precision therapies get to patients.
| 4 min read
Multiomic approaches are advancing cancer research by delivering deeper insights and enabling more precise diagnostics and therapies.
| 2 min read
The bioX Genetics Platform provides an advanced trusted research environment where users can access a range of cutting-edge analytical tools to manage and search genetic datasets
| 3 min read
Integrating scientific and engineering expertise is critical for enabling faster, more cost-effective drug discovery.
| 2 min read
Scientists and science journalists alike have a responsibility to communicate new discoveries with the utmost accuracy, sans hype.
| 3 min read
A changing dance of transcription factors modulates T regulatory cell gene expression in different immune contexts with implications for cancer and autoimmune diseases.
| 3 min read
Epilepsy onset and seizure severity are linked to variants in the SCN2A gene, potentially leading to improved diagnostics and treatments.
| 3 min read
Specialized cells in omental adipose tissue may repress fat cell development.
| 5 min read
Inspired by nature, Peel Therapeutics scientists look to evolution to find the next life changing drug.
